Kolon crashes on TG-C failure; NGeneBio soars [K-bio pulse]

Shares of three Kolon Group affiliates tumbled Tuesday after Kolon TissueGene's osteoarthritis cell and gene therapy TG-C formerly known as Invossa failed a late-stage U.S. clinical t...